Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Maverick Therapeutics revenue
Maverick Therapeutics's revenue is $10.0 million.
What is Maverick Therapeutics's revenue?
- Maverick Therapeutics has 34 employees, and the revenue per employee ratio is $294,118.
- Maverick Therapeutics peak revenue was $10.0M in 2024.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Maverick Therapeutics financing
Maverick Therapeutics received early financing of $125.0M on 2017-01-01.
| Series | Round size | Date |
|---|---|---|
| Series Unknown | $125M | 01/2017 |
Maverick Therapeutics investors
| Investors | Security type |
|---|---|
| Takeda | Series Unknown |
| MPM Capital | Series Unknown |
Search for jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Maverick Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Maverick Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Maverick Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Maverick Therapeutics. The data presented on this page does not represent the view of Maverick Therapeutics and its employees or that of Zippia.
Maverick Therapeutics may also be known as or be related to Maverick Therapeutics, Maverick Therapeutics Inc, Maverick Therapeutics Inc. and Maverick Therapeutics, Inc.